13 Jan 17

About NanoBio Corporation.NanoBio Corporation technology platform focuses the company ‘s lead product candidates are treatments for herpes labialis , onychomycosis , methicillin-resistant Staphylococcus aureus and mucosal vaccines for influenza and hepatitis B daily basis . The company’s headquarters and laboratory facilities are. In Ann Arbor, Michigan.

Associated Cardium therapeutic approach for the treatment of myocardial ischemia with coronary heart disease has become the focus of most commonly performed clinical studies for Angiogenic Gene Therapy , to date to date 663 patients at more than a hundred American, European and other international medical centers. Generx represents the first and only DNA-based cardiovascular therapeutic be promoted to Phase 3, and the company believes largely under-represented Phase 3 product candidate for the potential treatment of patients with stable angina, a chronic condition that affects millions of patients have in the U.S. And worldwide. Our just -initiated AWARE study is an important and timely clinical study and represents a significant milestone for Cardium There is a growing awareness that cardiovascular disease in men and women may be somewhat different and while men have long been a focus with. Respect to heart disease, it is well documented that women have been largely under-represented in cardiovascular clinical trials despite the fact that heart disease is now the leading cause of death among adult women in the U.S. And Europe, said Christopher J. Reinhard, Cardium Chairman and Chief Executive Officer. We are thrilled our lead compound previously shown to previously shown to be associated with significant improvement in myocardial blood flow, similar the order reported in the literature for patients undergoing angioplasty or bypass surgery. Is believed About Women and Heart Disease.

http://doxycycline-hcl.com/

About Cook MedicalCook Medical had among the first companies to implement interventional device in the U.S. Today, the company participates in all global markets, integrating device design, biopharma, gene and somatic cell treatment and biotech. To improve patient safety and and improve clinical outcomes. Kitchen won both the prestigious Medical Devices Manufacturer of the Year by the Medical Devices and Diagnostic IndustryStock magazine.